Potent bactericidal efficacy of copper oxide impregnated non-porous solid surfaces

BMC Microbiology

Gadi Borkow²  Ken Trinder¹  Vikram Kanmukhla²  Alastair B Monk² 

[1] EOS Surfaces, Norfolk, VA, USA;Cupron Inc, 800 East Leigh Street, Suite 123, Richmond, VA 23219, USA

关键词: Environmental bioburden;    Antimicrobial surface;    EPA registered;    Copper oxide;   

Others  :  1141739
DOI  :  10.1186/1471-2180-14-57

 received in 2013-10-09, accepted in 2014-02-28,  发布年份 2014

【 摘 要 】

Background

The role of fomites and the environment in nosocomial infections is becoming widely recognized. In this paper we discuss the use of Cupron copper oxide impregnated non-porous solid surface in the hospital setting and present in vitro testing data via USA Environmental Protection Agency (EPA) approved testing protocols that demonstrate the efficacy of these products to assist in reduction in environmental contamination and potentially nosocomial infections.

Results

The two countertops tested passed all the acceptance criteria by the EPA (>99.9% kill within 2 hours of exposure) killing a range of bacterial pathogens on the surface of the countertops even after repeated exposure of the countertops to the pathogen, and multiple wet and dry abrasion cycles.

Conclusions

Cupron enhanced EOS countertops thus may be an important adjunct to be used in hospital settings to reduce environmental bioburden and potentially nosocomial infections.

【 授权许可】

   
2014 Monk et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Valles J, Ferrer R: Bloodstream infection in the ICU. Infect Dis Clin North Am 2009, 23:557-569.
• [2]Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, Cardo DM: Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007, 122:160-166.
• [3]European Centre for Disease Prevention and Control: Annual epidemiological report on communicable diseases in Europe. Stockholm; 2010.
• [4]Kock R, Becker K, Cookson B, Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro TA, Witte W: Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 2010, 15:19688.
• [5]Ferguson JK: Preventing healthcare-associated infection: risks, healthcare systems and behaviour. Intern Med J 2009, 39:574-581.
• [6]Gouvernement du Québec: Loi modifiant la Loi sur les services de santé et les services sociaux concernant la prestation sécuritaire de services de santé et de services sociaux. 2009.
• [7]Hughes AJ, Ariffin N, Huat TL, Abdul MH, Hashim S, Sarijo J, Hughes AJ, Ariffin N, Huat TL, Abdul Molok H, Hashim S, Sarijo J, Abd Latif NH, Abu Hanifah Y, Kamarulzaman A: Prevalence of nosocomial infection and antibiotic use at a university medical center in Malaysia. Infect Control Hosp Epidemiol 2005, 26:100-104.
• [8]Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, Cuellar LE, Arikan OA, Abouqal R, Leblebicioglu H: Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006, 145:582-591.
• [9]Rosenthal VD: Device-associated nosocomial infections in limited-resources countries: findings of the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control 2008, 36:S171-12.
• [10]Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK: NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008, 29:996-1011.
• [11]Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K: International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302:2323-2329.
• [12]Roberts RR, Scott RD, Hota B, Kampe LM, Abbasi F, Schabowski S, Ahmad I, Ciavarella GG, Cordell R, Solomon SL, Hagtvedt R, Weinstein RA: Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care 2010, 48:1026-1035.
• [13]Curtis LT: Prevention of hospital-acquired infections: review of non-pharmacological interventions. J Hosp Infect 2008, 69:204-219.
• [14]Dancer SJ, White LF, Lamb J, Girvan EK, Robertson C: Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study. BMC Med 2009, 7:28. BioMed Central Full Text
• [15]Hamilton D, Foster A, Ballantyne L, Kingsmore P, Bedwell D, Hall TJ, Hickok SS, Jeanes A, Coen PG, Gant VA: Performance of ultramicrofibre cleaning technology with or without addition of a novel copper-based biocide. J Hosp Infect 2010, 74:62-71.
• [16]Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SR, McDougall C, Wilcox MH: epic2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007, 65(Suppl 1):S1-S64.
• [17]Wren MW, Rollins MS, Jeanes A, Hall TJ, Coen PG, Gant VA: Removing bacteria from hospital surfaces: a laboratory comparison of ultramicrofibre and standard cloths. J Hosp Infect 2008, 70:265-271.
• [18]Bhalla A, Pultz NJ, Gries DM, Ray AJ, Eckstein EC, Aron DC, Donskey CJ: Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol 2004, 25:164-167.
• [19]Boyce JM, Potter-Bynoe G, Chenevert C, King T: Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997, 18:622-627.
• [20]Eckstein BC, Adams DA, Eckstein EC, Rao A, Sethi AK, Yadavalli GK, Donskey CJ: Reduction of Clostridium Difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect Dis 2007, 7:61. BioMed Central Full Text
• [21]Goodman ER, Platt R, Bass R, Onderdonk AB, Yokoe DS, Huang SS: Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol 2008, 29:593-599.
• [22]Hayden MK, Bonten MJ, Blom DW, Lyle EA, van de Vijver DA, Weinstein RA: Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis 2006, 42:1552-1560.
• [23]Hota B: Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 2004, 39:1182-1189.
• [24]Lu PL, Siu LK, Chen TC, Ma L, Chiang WG, Chen YH, Lin SF, Chen TP: Methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii on computer interface surfaces of hospital wards and association with clinical isolates. BMC Infect Dis 2009, 9:164. BioMed Central Full Text
• [25]Mutters R, Nonnenmacher C, Susin C, Albrecht U, Kropatsch R, Schumacher S: Quantitative detection of Clostridium difficile in hospital environmental samples by real-time polymerase chain reaction. J Hosp Infect 2009, 71:43-48.
• [26]Sabino R, Sampaio P, Carneiro C, Rosado L, Pais C: Isolates from hospital environments are the most virulent of the Candida parapsilosis complex. BMC Microbiol 2011, 11:180. BioMed Central Full Text
• [27]Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E: Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 2010, 38:S25-S33.
• [28]Young JM, Naqvi M, Richards L: Microbial contamination of hospital bed handsets. Am J Infect Control 2005, 33:170-174.
• [29]Champagne VK, Helfritch DJ: A demonstration of the antimicrobial effectiveness of various copper surfaces. J Biol Eng 2013, 7:8. BioMed Central Full Text
• [30]Kramer A, Schwebke I, Kampf G: How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006, 6:130-138. BioMed Central Full Text
• [31]Borkow G, Monk AB: Fighting nosocomial infections with biocidal non-intrusive hard and soft surfaces. World J Clin Infect Dis 2012, 12:77-90.
• [32]Gould SWJ, Fielder MD, Kelly AF, Morgan M, Kenny J, Naughton DP: The antimicrobial properties of copper surfaces against a range of important nosocomial pathogens. Anal Microbiol 2009, 59:151-156.
• [33]Rai S, Hirsch BE, Attaway HH, Nadan R, Fairey S, Hardy J, Miller G, Armellino D, Moran WR, Sharpe P, Estelle A, Michel JH, Michels HT, Schmidt MG: Evaluation of the antimicrobial properties of copper surfaces in an outpatient infectious disease practice. Infect Control Hosp Epidemiol 2012, 33:200-201.
• [34]Casey AL, Adams D, Karpanen TJ, Lambert PA, Cookson BD, Nightingale P, Nightingale P, Miruszenko L, Shillam R, Christian P, Elliott TS: Role of copper in reducing hospital environment contamination. J Hosp Infect 2010, 74:72-77.
• [35]Karpanen TJ, Casey AL, Lambert PA, Cookson BD, Nightingale P, Miruszenko L, Elliott TS: The antimicrobial efficacy of copper alloy furnishing in the clinical environment: a crossover study. Infect Control Hosp Epidemiol 2012, 33:3-9.
• [36]Marais F, Mehtar S, Chalkley L: Antimicrobial efficacy of copper touch surfaces in reducing environmental bioburden in a South African community healthcare facility. J Hosp Infect 2010, 74:80-82.
• [37]Schmidt MG, Attaway HH, Sharpe PA, John J Jr, Sepkowitz KA, Morgan A, Fairey SE, Singh S, Steed LL, Cantey JR, Freeman KD, Michels HT, Salgado CD: Sustained reduction of microbial burden on common hospital surfaces through introduction of copper. J Clin Microbiol 2012, 50:2217-2223.
• [38]Efstathiou PA: The role of antimicrobial copper surfaces in reducing healthcare associated infections. Eur Infect Dis 2011, 5:125-128.
• [39]Salgado CD, Sepkowitz KA, John JF, Cantey JR, Attaway HH, Freeman KD, Sharpe PA, Michels HT, Schmidt MG: Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit. Infect Control Hosp Epidemiol 2013, 34:479-486.
• [40]Borkow G, Gabbay J: Putting copper into action: copper-impregnated products with potent biocidal activities. FASEB J 2004, 18:1728-1730.
• [41]Borkow G, Sidwell RW, Smee DF, Barnard DL, Morrey JD, Lara-Villegas HH, Shemer-Avni Y, Gabbay J: Neutralizing viruses in suspensions by copper oxide based filters. Antimicrob Agents Chemother 2007, 51:2605-2607.
• [42]Borkow G, Okon-Levy N, Gabbay J: Copper oxide impregnated wound dressings: biocidal and safety studies. Wounds 2010, 22:310-316.
• [43]Borkow G: Using copper to fight microorganisms. Curr Chem Biol 2012, 6:93-103.
• [44]Goto H, Shimada K, Ikemoto H, Oguri T: Antimicrobial susceptibility of pathogens isolated from more than 10,000 patients with infectious respiratory diseases: a 25-year longitudinal study. J Infect Chemother 2009, 15:347-360.
• [45]Durai R, Ng PC, Hoque H: Methicillin-resistant Staphylococcus aureus: an update. AORN J 2010, 91:599-606.
• [46]Maillard JY: Bacterial resistance to biocides in the healthcare environment: should it be of genuine concern? J Hosp Infect 2007, 65(Suppl 2):60-72.
• [47]Maillard JY: Antimicrobial biocides in the healthcare environment: efficacy, usage, policies, and perceived problems. Ther Clin Risk Manag 2005, 1:307-320.
• [48]Borkow G, Gabbay J: Copper as a biocidal tool. Curr Med Chem 2005, 12:2163-2175.
• [49]Borkow G, Gabbay J: An ancient remedy returning to fight microbial, fungal and viral infections. Curr Chem Biol 2009, 3:272-278.
• [50]Nan L, Liu Y, Lu M, Yang K: Study on antibacterial mechanism of copper-bearing austenitic antibacterial stainless steel by atomic force microscopy. J Mater Sci Mater Med 2008, 19:3057-3062.
• [51]Ohsumi Y, Kitamoto K, Anraku Y: Changes induced in the permeability barrier of the yeast plasma membrane by cupric ion. J Bacteriol 1988, 170:2676-2682.
• [52]Avery SV, Howlett NG, Radice S: Copper toxicity towards Saccharomyces cerevisiae: dependence on plasma membrane fatty acid composition. Appl Environ Microbiol 1996, 62:3960-3966.
• [53]Karlstrom AR, Levine RL: Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms. Proc Natl Acad Sci U S A 1991, 88:5552-5556.
• [54]Karlstrom AR, Shames BD, Levine RL: Reactivity of cysteine residues in the protease from human immunodeficiency virus: identification of a surface-exposed region which affects enzyme function. Arch Biochem Biophys 1993, 304:163-169.
• [55]Valko M, Morris H, Cronin MT: Metals, toxicity and oxidative stress. Curr Med Chem 2005, 12:1161-1208.
• [56]Espirito SC, Lam EW, Elowsky CG, Quaranta D, Domaille DW, Chang CJ, et al.: Bacterial killing by dry metallic copper surfaces. Appl Environ Microbiol 2011, 77:794-802.
• [57]Hans M, Erbe A, Mathews S, Chen Y, Solioz M, Mucklich F: Role of copper oxides in contact killing of bacteria. Langmuir 2013, 29:16160-16166.
• [58]Mathews S, Hans M, Mucklich F, Solioz M: Contact killing of bacteria on copper is suppressed if bacterial-metal contact is prevented and is induced on iron by copper ions. Appl Environ Microbiol 2013, 79:2605-2611.